{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:53:48Z","timestamp":1785902028861,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fish & Shellfish Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.fsi.2026.111520","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:20:14Z","timestamp":1781652014000},"page":"111520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Novel lytic phage vB-Vp-ZX1018 potentiates ofloxacin activity against multidrug-resistant Vibrio parahaemolyticus infections"],"prefix":"10.1016","volume":"176","author":[{"given":"Yue","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixing","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2515-704X","authenticated-orcid":false,"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fsi.2026.111520_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fmicb.2014.00705","article-title":"Vibrio parahaemolyticus: a review on the pathogenesis, prevalence, and advance molecular identification techniques","volume":"5","author":"Letchumanan","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.fsi.2026.111520_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/microorganisms7030084","article-title":"Phage endolysins as potential antimicrobials against multidrug resistant Vibrio alginolyticus and Vibrio parahaemolyticus: current status of research and challenges ahead","volume":"7","author":"Matamp","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.fsi.2026.111520_bib3","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2147\/IDR.S234186","article-title":"Pathogenic Characteristics of and Variation in Vibrio parahaemolyticus isolated from acute diarrhoeal patients in southeastern China from 2013 to 2017","volume":"13","author":"Chen","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.fsi.2026.111520_bib4","first-page":"131","article-title":"Review and guidelines for treatment of diarrhea caused by Vibrio parahaemolyticus","volume":"22","author":"Heitmann","year":"2005","journal-title":"Rev. Chil. infectol."},{"key":"10.1016\/j.fsi.2026.111520_bib5","first-page":"159","article-title":"Antibiotics in aquaculture \u2013 use, abuse and alternatives","author":"Romero","year":"2012","journal-title":"Health and Environment in Aquaculture"},{"key":"10.1016\/j.fsi.2026.111520_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage therapy: a renewed approach to combat antibiotic-resistant bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.fsi.2026.111520_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/138920110790725401","article-title":"Phage therapy in clinical practice: treatment of human infections","volume":"11","author":"Kutter","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.fsi.2026.111520_bib8","first-page":"17","article-title":"Molecular biology and biotechnology of bacteriophage","volume":"119","author":"Onodera","year":"2010","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"10.1016\/j.fsi.2026.111520_bib9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.fsi.2026.111520_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1749-4486.2009.01973.x","article-title":"A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy","volume":"34","author":"Wright","year":"2009","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.fsi.2026.111520_bib11","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.clinthera.2020.07.014","article-title":"Phage therapy in the resistance era: where do we stand and where are we going?","volume":"42","author":"Luong","year":"2020","journal-title":"Clin. Ther."},{"key":"10.1016\/j.fsi.2026.111520_bib12","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3389\/fmicb.2020.01947","article-title":"Combined bacteriophage and antibiotic treatment prevents Pseudomonas aeruginosa infection of wild type and cftr- epithelial cells","volume":"11","author":"Luscher","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.fsi.2026.111520_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/antibiotics13010094","article-title":"Laboratory evolution of antimicrobial resistance in bacteria to develop rational treatment strategies","volume":"13","author":"Maeda","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.fsi.2026.111520_bib14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s11033-025-11173-z","article-title":"Phage therapy for drug-resistant infections: mechanisms, evidence, and emerging clinical strategies","volume":"52","author":"Alaaeddine","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.fsi.2026.111520_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70193","article-title":"Phage-Antibiotic combinations for pseudomonas: successes in the clinic and in vitro tenuously connected","volume":"18","author":"Fatima","year":"2025","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.fsi.2026.111520_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00926-19","article-title":"Fitness trade-offs resulting from bacteriophage resistance potentiate synergistic antibacterial strategies","volume":"88","author":"Mangalea","year":"2020","journal-title":"Infect. Immun."},{"key":"10.1016\/j.fsi.2026.111520_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/antibiotics14060545","article-title":"The current landscape of phage-antibiotic synergistic (PAS) interactions","volume":"14","author":"Supina","year":"2025","journal-title":"Antibiotics"},{"key":"10.1016\/j.fsi.2026.111520_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/phar.2358","article-title":"Bacteriophage therapeutics: a primer for Clinicians on phage-antibiotic combinations","volume":"40","author":"Morrisette","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.fsi.2026.111520_bib19","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1038\/s41467-022-33294-w","article-title":"Bacteriophage-antibiotic combination therapy against extensively drug-resistant Pseudomonas aeruginosa infection to allow liver transplantation in a toddler","volume":"13","author":"Van Nieuwenhuyse","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.fsi.2026.111520_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/srep26717","article-title":"Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa","volume":"6","author":"Chan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fsi.2026.111520_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2022.111986","article-title":"Phage controlling method against novel freshwater-derived Vibrio parahaemolyticus in ready-to-eat crayfish (Procambarus clarkii)","volume":"162","author":"Teng","year":"2022","journal-title":"Food Res. Int."},{"key":"10.1016\/j.fsi.2026.111520_bib22","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/s41564-024-01719-5","article-title":"Bacteriophage protein Dap1 regulates evasion of antiphage immunity and Pseudomonas aeruginosa virulence impacting phage therapy in mice","volume":"9","author":"Le","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.fsi.2026.111520_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.aquaculture.2024.741499","article-title":"Biological characteristics of bacteriophage vB_Va_ZX-1 and its therapeutic effect on Chinese mitten crab infected by Vibrio alginolyticus","volume":"595","author":"Zhang","year":"2025","journal-title":"Aquaculture"},{"key":"10.1016\/j.fsi.2026.111520_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodcont.2025.111424","article-title":"Exploring the efficacy of bacteriophage cocktails for mitigating vibrio contamination within the seafood production chain: a feasible approach to microbial risk management","volume":"177","author":"Zhang","year":"2025","journal-title":"Food Control"},{"key":"10.1016\/j.fsi.2026.111520_bib25","first-page":"703","article-title":"Synergistic interaction between phage therapy and antibiotics clears Pseudomonas Aeruginosa infection in endocarditis and reduces virulence","volume":"215","author":"Oechslin","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.fsi.2026.111520_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnaa159","article-title":"Assessment of phage-mediated inhibition of Salmonella Typhimurium treated with sublethal concentrations of ceftriaxone and ciprofloxacin","volume":"367","author":"Jeon","year":"2020","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.fsi.2026.111520_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/nyas.14533","article-title":"Phage-antibiotic combinations: a promising approach to constrain resistance evolution in bacteria","volume":"1496","author":"North","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.fsi.2026.111520_bib28","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.1038\/s41467-024-53994-9","article-title":"A blueprint for broadly effective bacteriophage-antibiotic cocktails against bacterial infections","volume":"15","author":"Kim","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.fsi.2026.111520_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00096-22","article-title":"Bactericidal synergism between phage YC#06 and antibiotics: a combination strategy to target multidrug-resistant Acinetobacter baumannii in vitro and In Vivo","volume":"10","author":"Luo","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.fsi.2026.111520_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12929-022-00806-1","article-title":"Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far","volume":"29","author":"\u0141usiak-Szelachowska","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.fsi.2026.111520_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011602","article-title":"Phage-antibiotic synergy: cell filamentation is a key driver of successful phage predation","volume":"19","author":"Bulssico","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.fsi.2026.111520_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105732","article-title":"Phage resistance-mediated trade-offs with antibiotic resistance in Salmonella Typhimurium","volume":"171","author":"Laure","year":"2022","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.fsi.2026.111520_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00461-20","article-title":"Bacteriophage-antibiotic combination strategy: an alternative against methicillin-resistant phenotypes of Staphylococcus aureus","volume":"64","author":"Kebriaei","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fsi.2026.111520_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1356179","article-title":"Phage-antibiotic combinations in various treatment modalities to manage MRSA infections","volume":"15","author":"Loganathan","year":"2024","journal-title":"Front. Pharmacol."}],"container-title":["Fish & Shellfish Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050464826004249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050464826004249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:32:54Z","timestamp":1785900774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050464826004249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S1050464826004249"],"URL":"https:\/\/doi.org\/10.1016\/j.fsi.2026.111520","relation":{},"ISSN":["1050-4648"],"issn-type":[{"value":"1050-4648","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel lytic phage vB-Vp-ZX1018 potentiates ofloxacin activity against multidrug-resistant Vibrio parahaemolyticus infections","name":"articletitle","label":"Article Title"},{"value":"Fish & Shellfish Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fsi.2026.111520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111520"}}